AIM Vaccine Co Ltd Class H 06660
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$11.80
- Day Range
- HK$10.30–11.80
- 52-Week Range
- HK$3.95–31.10
- Bid/Ask
- HK$10.66 / HK$10.80
- Market Cap
- HK$13.08 Bil
- Volume/Avg
- 1.0 Mil / 774,450
Key Statistics
- Price/Earnings (Normalized)
- 28.84
- Price/Sales
- 10.17
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates all of its revenues in the PRC.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,557
- Website
- https://www.aimbio.com
Comparables
Valuation
Metric
|
06660
|
300841
|
300601
|
---|---|---|---|
Price/Earnings (Normalized) | 28.84 | 14.47 | 39.64 |
Price/Book Value | 5.27 | 2.58 | 2.29 |
Price/Sales | 10.17 | 5.21 | 7.40 |
Price/Cash Flow | — | 12.08 | 19.46 |
Price/Earnings
06660
300841
300601
Financial Strength
Metric
|
06660
|
300841
|
300601
|
---|---|---|---|
Quick Ratio | 0.67 | 4.18 | 1.16 |
Current Ratio | 0.85 | 4.57 | 1.68 |
Interest Coverage | −38.31 | 124.81 | 4.31 |
Quick Ratio
06660
300841
300601
Profitability
Metric
|
06660
|
300841
|
300601
|
---|---|---|---|
Return on Assets (Normalized) | −3.14% | 15.47% | 2.83% |
Return on Equity (Normalized) | −6.94% | 18.16% | 4.36% |
Return on Invested Capital (Normalized) | −3.60% | 17.07% | 3.57% |
Return on Assets
06660
300841
300601
Biotechnology Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Novo Nordisk AS ADR
NVO
| Ljvwpfywkp | Hhr | $516.0 Bil | |||
Vertex Pharmaceuticals Inc
VRTX
| Qjjpfkgv | Sbytdy | $117.1 Bil | |||
Regeneron Pharmaceuticals Inc
REGN
| Fjyvxny | Ymhhmf | $111.8 Bil | |||
Alnylam Pharmaceuticals Inc
ALNY
| Tvtggpl | Gktkt | $34.6 Bil | |||
argenx SE ADR
ARGX
| Vwhbkbk | Jkpp | $33.0 Bil | |||
BioNTech SE ADR
BNTX
| Pcfrjglp | Grjnd | $28.5 Bil | |||
Moderna Inc
MRNA
| Rcssnjbg | Vtqkl | $23.5 Bil | |||
United Therapeutics Corp
UTHR
| Lssytyzvw | Fhx | $15.6 Bil | |||
Biomarin Pharmaceutical Inc
BMRN
| Vgthngc | Bwnjbb | $13.0 Bil | |||
Incyte Corp
INCY
| Zqwslzbd | Xrfnhkh | $12.9 Bil |